Search research articles
Contact Us
Filters
Showing results (351-360 of 368) with videos related to
Page
of 37
Sort By:
Hepatology Communications
|
February 7, 2018
Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic review
Sofia R Bartlett, Jason Grebely, Auda A Eltahla, et al.
The International Journal on Drug Policy
|
February 6, 2026
Global coverage of interventions for reduction of injecting drug use-related harm, HIV, viral hepatitis and tuberculosis in prisons and other carceral settings: A systematic review
Thomas Santo, Matthew Hickman, Frederick L Altice, et al.
The International Journal on Drug Policy
|
February 6, 2026
The global epidemiology of injecting drug use, HIV, viral hepatitis and tuberculosis among people who are incarcerated: a multistage systematic review
Louisa Degenhardt, Matthew Hickman, Frederick L Altice, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|
January 10, 2017
Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection
Chaturaka Rodrigo, Melanie R Walker, Preston Leung, et al.
Annals of Internal Medicine
|
August 19, 2016
Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial
Gregory J Dore, Frederick Altice, Alain H Litwin, et al.
The International Journal on Drug Policy
|
January 6, 2026
Interventions to improve testing, linkage to care, and treatment for hepatitis C infection in prison: a systematic review and meta-analysis
Evan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al.
JHEP Reports : Innovation in Hepatology
|
April 18, 2022
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals
Anita Y M Howe, Chaturaka Rodrigo, Evan B Cunningham, et al.
The International Journal on Drug Policy
|
July 8, 2017
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
Jason Grebely, Julie Bruneau, Jeffrey V Lazarus, et al.
The International Journal on Drug Policy
|
June 24, 2025
Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study
Joshua Ang, Behzad Hajarizadeh, Shane Tillakeratne, et al.
Nordisk Alkohol- & Narkotikatidskrift : NAT
|
April 7, 2025
A clarion call to the addiction science community: It's time to resist the anti-scientific policies of the US Trump administration
Thomas F Babor, Bryon Adinoff, Luke Clark, et al.
Page
of 37
Search research articles
Search
Showing results (351-360 of 368) with videos related to
Sort By:
Page
of 37
Hepatology Communications
|
February 7, 2018
Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic review
Sofia R Bartlett, Jason Grebely, Auda A Eltahla, et al.
The International Journal on Drug Policy
|
February 6, 2026
Global coverage of interventions for reduction of injecting drug use-related harm, HIV, viral hepatitis and tuberculosis in prisons and other carceral settings: A systematic review
Thomas Santo, Matthew Hickman, Frederick L Altice, et al.
The International Journal on Drug Policy
|
February 6, 2026
The global epidemiology of injecting drug use, HIV, viral hepatitis and tuberculosis among people who are incarcerated: a multistage systematic review
Louisa Degenhardt, Matthew Hickman, Frederick L Altice, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|
January 10, 2017
Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection
Chaturaka Rodrigo, Melanie R Walker, Preston Leung, et al.
Annals of Internal Medicine
|
August 19, 2016
Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial
Gregory J Dore, Frederick Altice, Alain H Litwin, et al.
The International Journal on Drug Policy
|
January 6, 2026
Interventions to improve testing, linkage to care, and treatment for hepatitis C infection in prison: a systematic review and meta-analysis
Evan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al.
JHEP Reports : Innovation in Hepatology
|
April 18, 2022
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals
Anita Y M Howe, Chaturaka Rodrigo, Evan B Cunningham, et al.
The International Journal on Drug Policy
|
July 8, 2017
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
Jason Grebely, Julie Bruneau, Jeffrey V Lazarus, et al.
The International Journal on Drug Policy
|
June 24, 2025
Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study
Joshua Ang, Behzad Hajarizadeh, Shane Tillakeratne, et al.
Nordisk Alkohol- & Narkotikatidskrift : NAT
|
April 7, 2025
A clarion call to the addiction science community: It's time to resist the anti-scientific policies of the US Trump administration
Thomas F Babor, Bryon Adinoff, Luke Clark, et al.
Page
of 37